OPKO Health, Inc. (NASDAQ:OPK) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the OPKO Health Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
Opko Health Inc. (OPK)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 47,791,243 | $74,076,427 | 0.84% | |
| 2. | 9,350,000 | $14,394,046 | 4.25% | ||
| 3. | Whitefort Capital David Salanic | 4,900,000 | $7,595,000 | +177% | 2.24% |
| 4. | AQR Capital Management Cliff Asness | 2,873,416 | $4,453,795 | +208% | 0% |
| 5. | 2,000,000 | $3,078,190 | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.34 | 192,870 | $257,481.45 | 216,706,448 | 2025-11-21 | Filing | |
| $1.33 | 191,490 | $254,681.70 | 216,513,578 | 2025-11-21 | Filing | |
| $1.33 | 89,375 | $118,421.88 | 216,322,088 | 2025-11-21 | Filing | |
| $1.32 | 3,894 | $5,140.08 | 216,232,713 | 2025-11-21 | Filing | |
| $1.30 | 102,371 | $133,082.30 | 216,228,819 | 2025-11-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.07 | 112,975 | $911,674.36 | 161,293 | 2017-03-14 | Filing | |
| $9.85 | 3,000 | $29,535.00 | 284,088 | 2016-05-13 | Filing | |
| $9.84 | 5,616 | $55,261.44 | 287,088 | 2016-05-13 | Filing | |
| $9.84 | 900 | $8,851.50 | 292,704 | 2016-05-13 | Filing | |
| $9.83 | 4,000 | $39,320.00 | 293,604 | 2016-05-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 37,535,897 | $58,180,641 | 0% | |
| 2. | 33,172,384 | $51,417,196 | 0% | |
| 3. | 12,950,000 | $19,934,843 | 0.15% | |
| 4. | 10,993,345 | $17,043,109 | 0% | |
| 5. | 8,997,940 | $13,946,807 | 0% |
News See All
Opko Health Inc.'s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals
Opko Health Inc. (NASDAQ:OPK) is one of the best stocks under $5 with highest upside potential. ModeX Therapeutics Inc., an Opko Health Inc.
14 Stocks Under $5 with Highest Upside Potential
On October 28, Paul Tudor Jones, Tudor Investment Corporation founder and CIO and Robin Hood Foundation founder and board member, appeared on CNBC’s 'Squawk Box' to talk about the latest trends in the...
OPKO Health, Inc. (OPK)’s ModeX Division Pushes Four Immuno-Oncology Candidates into Phase 1
OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company with operations spanning diagnostics, pharmaceuticals, and innovative therapies.
12 Healthcare Stocks with Insider Buying in 2025
In 2025, there will be a complicated combination of opportunities and difficulties in the healthcare innovation landscape, with divergent trends in technology adoption, investment, and fundraising.
12 Best Healthcare Stocks to Buy Under $30
Mizuho health care sector strategist Jared Holz made an appearance on CNBC's "The Exchange" on July 21 to discuss the challenges facing the healthcare industry and whether there are any opportunities ...
Opko Health (OPK) Reports Fiscal Q2 2025 Results
Opko Health Inc. (NASDAQ:OPK) is one of the best strong buy penny stocks to buy now. On July 31, Opko Health Inc.
10 Best Strong Buy Penny Stocks to Buy Now
On July 28, Alan Rechtschaffen, UBS Global Wealth senior portfolio manager, appeared on CNBC’s ‘Money Movers’ to talk about the markets, his Fed outlook, and more.
OPKO Health, Inc. (NASDAQ:OPK) Q2 2025 Earnings Call Transcript
Operator: Good day, and welcome to the OPKO Health Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.